In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

• James F. Howard, Jr.,
• Susan M. Manzi,
• Milos D. Miljkovic,
• Tuan Vu,
• Tahseen Mozaffar

Affiliations

James F. Howard, Jr.

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Corresponding author.

Susan M. Manzi

Allegheny Health Network, Lupus Center of Excellence, Pittsburgh, PA, USA

Milos D. Miljkovic

Cartesian Therapeutics, Gaithersburg, MD, USA

Tuan Vu

University of South Florida, Tampa, FL, USA

Tahseen Mozaffar

University of California Irvine, CA, USA